pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
445
stories
17h
Cellectis quits CAR-T and pivots to ‘in vivo’ gene editing
biopharma dive
20h
Scholar Rock SMA drug approved by FDA
biopharma dive
20h
Lilly cans early experimental obesity drug after ‘high bar’ not met
fiercebiotech
22h
Axoltis misses the mark in phase 2 ALS study, but will persevere with the synthetic peptide
fiercebiotech
23h
Corbus posts phase 1 obesity data for drug mechanism that defeated Novo, Sanofi
fiercebiotech
1d
Opinion: Restoring public trust in science doesn’t have a simple solution. That’s OK
stat
1d
Cellectis cans allogeneic CAR-Ts to hop aboard in vivo bandwagon
fiercebiotech
1d
Psychedelic therapies ride wave of public favor into FDA hearing
biospace
1d
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
biospace
3d
This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree
biopharma dive
3d
Definium LSD drug goes 3 for 3 with another pivotal anxiety trial win
fiercebiotech
3d
Boycott launched against American Diabetes Association includes journal
stat
4d
In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy
fiercebiotech
4d
Takeda’s long-term R&D head announces exit after major pipeline reorganization
biospace
4d
The signal that changes everything: understanding MRD in oncology drug development
fiercebiotech
4d
Andy Plump, architect of Takeda’s R&D overhaul, to retire next year
biopharma dive
4d
FDA places partial hold on Biohaven's ion channel drug
endpoints
4d
STAT+: Cancer medicines remain in short supply across the U.S., survey finds
stat
5d
From process to intelligence: How AI is reshaping people strategy in life sciences
biospace
5d
Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules
fda medwatch
5d
Merck adds 53 to New Jersey chopping block
biospace
5d
FDA gains ‘continuity’ as Mikhail, Davis named permanent CBER, CDER leaders
biopharma dive
5d
Webinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and Markets
biospace
5d
Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision
biospace
5d
Telemedicine company offers GLP-1s for addiction
stat
5d
Kura Oncology spins out diabetes pipeline with $50M and Lilly's help
endpoints
6d
Tyra rolls toward pivotal bladder cancer study even as midphase data deflates stock
fiercebiotech
6d
STAT+: Can AI fix health care? In the chaos of emergency rooms, the technology comes up short
stat
6d
Opinion: AMA CEO: AI won’t replace doctors — it will work alongside them
stat
6d
Opinion: Autonomous AI will beat AI-assisted physicians at some medical tasks by 2030
stat
← prev
page 1 of 15
next →
